BBSRC Portfolio Analyser

BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Investigator / Supervisor details

NameDr Karen Philpott
Current InstitutionGlaxoSmithKline plc (remove)
Current DepartmentHarlow
Previous Institutions

Current Awards

No current BBSRC awards

Completed Awards

ReferenceTitleAward RoleValue £Type
99/A2/C/05060 Regulations of neural survival and death by novel Fas/TNF/p75-like receptors Co-Supervisor 35,156 Studentships
terms and conditions of use (opens in new window)
export PDF file
back to list new search